Monday, October 31, 2022

Monoclonal antibody prevents malaria infection in African adults

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).

 

10/31/2022 08:15 PM EDT

Antibody protected NIH clinical trial participants during six-month malaria season.

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) · 9000 Rockville Pike · Bethesda MD 20892 · 301-496-4000 / TTY 301-402-9612 GovDelivery logo

No comments:

Post a Comment

🐤 Meme stocks are roaring again. This time may be different

Meme stocks are shaking Wall Street once again. That shouldn't be much of a surprise. Ever since bands of smaller-pocketed and novice i...